A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

This study is currently recruiting participants.

Verified October 2012 by Sarcoma Alliance for Research through Collaboration

Sponsor:

Collaborator:

AstraZeneca

Information provided by:

Sarcoma Alliance for Research through Collaboration

ClinicalTrials.gov Identifier:

NCT00752206

First received: September 11, 2008

Last updated: October 29, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2014
Estimated Primary Completion Date:	September 2014 (Final data collection date for primary outcome measure)